| Net earnings | |
| Loss from discontinued operation, net of tax | |
| Depreciation | 11.71M |
| Amortization | 3.17M |
| Share-based compensation expense | 3.07M |
| Gain on sale of equity investment | |
| (Gain) Loss on foreign currency remeasurements and transactions | |
| Deferred income taxes | 1.52M |
| Excess tax benefits from share-based compensation expense | -139K |
| Earnings from equity investments | -331K |
| Accounts receivable | 8.28M |
| Inventories | -7.55M |
| Accounts payable | 8.34M |
| Income taxes payable | |
| Other operating net assets | -5.85M |
| Continuing operations | |
| Discontinued operation | |
| Net cash provided by operating activities | 19.51M |
| Additions to property, plant and equipment | -29.99M |
| Purchases of businesses, net of cash acquired | |
| Investments in unconsolidated businesses | |
| Proceeds from collection of notes receivable | |
| Other investing activities | 145K |
| Payments on deferred purchase price of businesses | |
| Continuing operations | -29.85M |
| Discontinued operation | |
| Net cash used in investing activities | |
| Proceeds on long-term borrowings | |
| Payments on long-term borrowings | -10M |
| Proceeds from exercise of stock options | 1.75M |
| Excess tax benefits from share-based compensation expense | |
| Payments on cash earnout arrangement | |
| Payments of deferred financing costs | |
| Purchases of treasury stock | 0 |
| Net cash provided by (used in) financing activities | 12.27M |
| Effect of exchange rate changes on cash and cash equivalents | -283K |
| Net increase in cash and cash equivalents | 1.65M |
| Cash and Cash Equivalents at Beginning of Period | 218.45M |
| Cash and Cash Equivalents at End of Period | 220.1M |
| Purchase of business by issuing Common Stock of the Company | |
| Purchases of business utilizing earnout consideration recorded in current and long-term liabilities | |